Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.


Disease Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Blood Disorders, Sickle Cell Disease Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach COH
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCSF
Clinical Trial, Phase 1 or Phase 1/2
Kidney Disease, Kidney Failure Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Medeor Therapeutics
Clinical Trial, Phase 3
Cancer, Lung Cancer, Solid Tumors Adult or Tissue Stem Cell Antibody, Biologic, Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCLA
Clinical Trial, Phase 1 or Phase 1/2
Blood Cancer, Blood Disorders, Bone Marrow Transplant and Viral Infection, Cancer Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach CHLA
Clinical Trial, Phase 1 or Phase 1/2
Retinitis Pigmentosa, Vision Loss Other Donor cell therapy, Therapeutic Approach jCyte
Clinical Trial, Phase 2
Diabetes, Metabolic Disorders, Type 1 diabetes Embryonic Stem Cell Device, Donor cell therapy, Therapeutic Approach ViaCyte
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, Immune Disease, Severe Combined Immunodeficiency, X-linked (X-SCID) Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach St. Jude
Clinical Trial, Phase 1 or Phase 1/2
Kidney Disease, Kidney Failure Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Stanford
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, Genetic Disorder, Immune Disease, Pediatrics, Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCLA
Clinical Trial, Phase 2
Alpha Thalassemia Major, Blood Disorders Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach UCSF
Clinical Trial, Phase 1 or Phase 1/2
Blood Cancer, Cancer, HIV-related Lymphoma, HIV/AIDS, Infectious Disease Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UC Davis
Clinical Trial, Phase 1 or Phase 1/2
Blood Disorders, Immune Disease, Pediatrics, X-linked Chronic Granulomatous Disease Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCLA
Clinical Trial, Phase 1 or Phase 1/2
Bone or Cartilage Disease, Cartilage defect Somatic Cell Donor cell therapy, Therapeutic Approach UC Irvine
IND
Amyotrophic Lateral Sclerosis, Neurological Disorders Biologic, Nucleic acid based therapy, Therapeutic Approach AcuraStem Inc.
IND
Blood Cancer, Cancer, Leukemia, Acute Myeloid (AML) Small molecule therapy, Therapeutic Approach Aspera Biomedicines, Inc.
IND
Neurological Disorders, Parkinson's Disease iPS Cell Donor cell therapy, Therapeutic Approach Ryne Biotechnology
IND
Age-related macular degeneration, Vision Loss iPS Cell Personalized cell therapy, Therapeutic Approach UCLA
IND
Genetic Disorder, Metabolic Disorders Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach Rampart Bioscience
IND
Breast Cancer, Cancer, Melanoma, Solid Tumors Somatic Cell Donor cell therapy, Therapeutic Approach Calidi Biotherapeutics, Inc.
IND
B cell cancers, Blood Cancer, Cancer, Solid Tumors Cancer Stem Cell Biologic, Protein/peptide therapy, Therapeutic Approach Nammi Therapeutics, Inc.
IND
Immune Disease Adult or Tissue Stem Cell Donor cell therapy, Therapeutic Approach Ossium Health, Inc.
IND
Genetic Disorder, Metabolic Disorders, Neurological Disorders, Pediatrics Somatic Cell Stanford
IND
Neurological Disorders Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Personalized cell therapy, Therapeutic Approach UC Davis
IND
Blood Cancer, Cancer, Leukemia, Acute Myeloid (AML) Cancer Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCSF
IND
Blood Disorders, X-linked Chronic Granulomatous Disease Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach ImmunoVec
Clinical Trial, Phase 1 or Phase 1/2
Skin Disease, Wounds, ulcers Small molecule therapy, Therapeutic Approach UCLA
IND
Bone or Cartilage Disease, Cartilage defect Embryonic Stem Cell Donor cell therapy, Therapeutic Approach USC
IND
Blood Cancer, Cancer Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach UCSD
IND
Huntington's Disease, Neurological Disorders Embryonic Stem Cell Donor cell therapy, Therapeutic Approach UC Irvine
IND
Brain Cancer, Cancer, Solid Tumors Adult or Tissue Stem Cell Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach COH
IND
1 2 3 4
Displaying 151 - 181 of 181